2013
DOI: 10.1111/dsu.12306
|View full text |Cite
|
Sign up to set email alerts
|

Commentary: Comparison of Outcomes for Malignant Melanoma of the Face Treated with Mohs Micrographic Surgery and Wide Local Excision

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 8 publications
(7 reference statements)
0
2
0
Order By: Relevance
“…[2][3][4]11,18,33,[39][40][41] Although the 2012 Appropriate Use Criteria has included the implementation of MMS for MIS, the technique is still underused despite the potential advantages. 7,42 For instance, based on Medicare data until 2013, only 0.3%-3.5% of Mohs cases in the United States were performed on melanomas, 38,43,44 and rates of utilization of Mohs for MIS do not seem to have increased. 7 However, given the potential advantages of Mohs and its controversial role in the management of melanoma, the authors felt it was timely to compare its use in relation with the oncologic standard of care in the context of the emerging data.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…[2][3][4]11,18,33,[39][40][41] Although the 2012 Appropriate Use Criteria has included the implementation of MMS for MIS, the technique is still underused despite the potential advantages. 7,42 For instance, based on Medicare data until 2013, only 0.3%-3.5% of Mohs cases in the United States were performed on melanomas, 38,43,44 and rates of utilization of Mohs for MIS do not seem to have increased. 7 However, given the potential advantages of Mohs and its controversial role in the management of melanoma, the authors felt it was timely to compare its use in relation with the oncologic standard of care in the context of the emerging data.…”
mentioning
confidence: 99%
“…2–4,11,18,33,39–41 Although the 2012 Appropriate Use Criteria has included the implementation of MMS for MIS, the technique is still underused despite the potential advantages. 7,42 For instance, based on Medicare data until 2013, only 0.3%–3.5% of Mohs cases in the United States were performed on melanomas, 38,43,44 and rates of utilization of Mohs for MIS do not seem to have increased. 7…”
mentioning
confidence: 99%